We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the BIOBADADERM registry.
- Authors
Ruiz Genao, Diana P.; Carretero, Gregorio; Rivera‐Diaz, Raquel; Carrascosa, Jose Manuel; Sahuquillo‐Torralba, Antonio; Herrera‐Acosta, Enrique; García, Francisco José Gómez; Daudén, Esteban; Estebaranz, Jose Luis López; Garcia‐Doval, Ignacio
- Abstract
Regarding therapy, almost all clinical trials exclude patients with pustular psoriasis, limiting the evidence to support therapy for these patients. G.C. has been reimbursed by Janssen, Abbvie, Novartis, Pfizer, MSD and Celgene for advisory service and conferences. There were 3864 patients with PP, 41 patients with generalized pustular psoriasis (GPP) and 294 patients with palmoplantar pustular psoriasis (PPP) included in the study.
- Subjects
PSORIASIS; HEART failure; EPIDEMIOLOGY; PSORIATIC arthritis; COMORBIDITY
- Publication
British Journal of Dermatology, 2022, Vol 187, Issue 5, p817
- ISSN
0007-0963
- Publication type
Article
- DOI
10.1111/bjd.21763